FindTrial
Sign In

Elective Endovascular Treatment for Intracranial Artery Stenosis or Occlusion: Impact of Total Intravenous versus Inhalational Anesthesia on Recovery Outcomes

Effects of Total Intravenous Anesthesia Versus Inhalational Anesthesia on Prognosis in Patients with Intracranial Artery Stenosis or Occlusion Undergoing Elective Endovascular Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120584
Enrollment
Unknown
Registered
2026-03-17
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Artery Stenosis or Occlusion

Interventions

Sevoflurane continuous inhalation group (Group S):Sevoflurane inhalation throughout the procedure
Propofol?remifentanil total intravenous anesthesia group (Group P):Propofol-remifentanil total intravenous anesthesia

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-80 years, regardless of gender; 2.patients scheduled for elective intracranial arterial endovascular treatment; 3.American Society of Anesthesiologists (ASA) physical status classification Grade II-IV; 4.written informed consent obtained from the patient or their legal representative.

Exclusion criteria

Exclusion criteria: 1.Allergy to Propofol, Remifentanil, or inhalational anesthetics; 2.Comorbidity of other untreated intracranial lesions (e.g., aneurysms, arteriovenous malformations [AVMs], tumors); 3.Severe cardiac, pulmonary, hepatic, or renal insufficiency; 4.History of or suspected history of malignant hyperthermia (MH); 5.Pregnancy or lactation in females; 6.Patients with consciousness disturbance; 7.Patients unable to cooperate with follow-up completion.

Design outcomes

Primary

MeasureTime frame
NIHSS score 24 hours postoperatively;—

Countries

China

Contacts

Public ContactGao Jin

The First Affiliated Hospital of Chongqing Medical University

137777547@qq.com+86 23 8901 1876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026